Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC+CIK with S-1 vs S-1 alone in advanced PDAC
NCT05955157Phase 3Unknown
- Sponsor
- Universiti Malaya
- Start
- Jan 2023
- Primary completion
- Dec 2024
- Modality
- Prophylactic Vaccines, Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of dendritic cell vaccine + cytokine-induced killer cells in pancreatic ductal adenocarcinoma (PDAC), sponsored by Universiti Malaya. Status: unknown.
02
Drugs
dendritic cell vaccine + cytokine-induced killer cells
03
Conditions
pancreatic ductal adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT05955157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05955157.